Bristol Historical Financial Ratios

BMY Stock

USD 59.18 0.28 0.48%

Bristol Myers is presently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0274, PTB Ratio of 6.94 or Days Sales Outstanding of 60.07 will help investors to properly organize and evaluate Bristol Myers Squibb financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Bristol Financial Ratios Analysis

Bristol Myers SquibbFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Bristol Myers investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Bristol financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Bristol Myers history.

Bristol Myers Financial Ratios Chart

At this time, Bristol Myers' PFCF Ratio is fairly stable compared to the past year. EV To Free Cash Flow is likely to rise to 11.71 in 2025, whereas Dividend Yield is likely to drop 0.03 in 2025.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Bristol Myers Squibb stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Bristol Myers sales, a figure that is much harder to manipulate than other Bristol Myers Squibb multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Bristol Myers Squibb dividend as a percentage of Bristol Myers stock price. Bristol Myers Squibb dividend yield is a measure of Bristol Myers stock productivity, which can be interpreted as interest rate earned on an Bristol Myers investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Bristol Myers' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Bristol Myers Squibb current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At this time, Bristol Myers' PFCF Ratio is fairly stable compared to the past year. EV To Free Cash Flow is likely to rise to 11.71 in 2025, whereas Dividend Yield is likely to drop 0.03 in 2025.

	2022	2023	2024	2025 (projected)
Dividend Yield	0.0302	0.0447	0.0424	0.0274
Price To Sales Ratio	3.32	2.36	2.37	2.95

Dividend Yield Price To Sales Ratio

Bristol Myers fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.71	0.51	0.15	-0.03	-0.78	-0.65	0.48	0.51	0.95	-0.67	-0.51	-0.22	0.19	0.18	-0.54	0.41	-0.27	0.86	-0.22	0.55	0.51	0.76	0.57	0.26	0.25
Dividend Yield	-0.71		-0.33	-0.02	-0.04	0.73	0.51	-0.48	-0.33	-0.67	0.52	0.51	0.26	0.0	-0.33	-0.06	-0.53	0.08	-0.62	0.33	-0.33	-0.54	-0.57	-0.04	-0.14	-0.1
Ptb Ratio	0.51	-0.33		0.0	-0.62	-0.35	-0.23	0.34	1.0	0.38	-0.26	0.02	0.16	-0.29	-0.25	-0.24	0.51	-0.41	0.49	0.04	0.28	0.37	0.47	0.2	0.0	-0.26
Days Sales Outstanding	0.15	-0.02	0.0		0.43	-0.11	0.13	0.02	0.0	0.27	0.1	-0.17	0.3	0.55	-0.26	-0.01	0.06	0.34	0.09	-0.27	0.34	0.05	0.09	-0.18	0.46	0.38
Book Value Per Share	-0.03	-0.04	-0.62	0.43		0.2	0.34	-0.43	-0.62	0.23	0.35	-0.51	-0.12	0.16	0.25	0.01	-0.47	0.71	-0.2	-0.43	-0.1	-0.38	-0.22	-0.1	0.09	-0.01
Free Cash Flow Yield	-0.78	0.73	-0.35	-0.11	0.2		0.91	-0.79	-0.35	-0.66	0.92	0.33	0.2	-0.34	-0.19	0.2	-0.62	0.45	-0.82	0.02	-0.59	-0.79	-0.77	-0.31	-0.32	-0.51
Operating Cash Flow Per Share	-0.65	0.51	-0.23	0.13	0.34	0.91		-0.82	-0.23	-0.48	1.0	0.21	0.33	-0.36	-0.28	0.29	-0.59	0.64	-0.74	-0.21	-0.62	-0.76	-0.7	-0.44	-0.35	-0.57
Capex To Depreciation	0.48	-0.48	0.34	0.02	-0.43	-0.79	-0.82		0.34	0.31	-0.84	-0.02	-0.2	0.24	0.16	0.07	0.88	-0.6	0.7	0.17	0.42	0.95	0.74	0.01	0.2	0.43
Pb Ratio	0.51	-0.33	1.0	0.0	-0.62	-0.35	-0.23	0.34		0.38	-0.26	0.02	0.16	-0.29	-0.25	-0.24	0.51	-0.41	0.49	0.04	0.28	0.37	0.47	0.2	0.0	-0.26
Ev To Sales	0.95	-0.67	0.38	0.27	0.23	-0.66	-0.48	0.31	0.38		-0.49	-0.6	-0.21	0.16	0.2	-0.51	0.24	-0.06	0.77	-0.38	0.46	0.36	0.67	0.5	0.22	0.16
Free Cash Flow Per Share	-0.67	0.52	-0.26	0.1	0.35	0.92	1.0	-0.84	-0.26	-0.49		0.2	0.32	-0.36	-0.26	0.29	-0.62	0.64	-0.75	-0.21	-0.62	-0.79	-0.71	-0.42	-0.36	-0.56
Roic	-0.51	0.51	0.02	-0.17	-0.51	0.33	0.21	-0.02	0.02	-0.6	0.2		0.26	-0.02	-0.28	0.23	0.01	-0.03	-0.35	0.55	-0.46	-0.13	-0.3	-0.28	-0.37	-0.03
Inventory Turnover	-0.22	0.26	0.16	0.3	-0.12	0.2	0.33	-0.2	0.16	-0.21	0.32	0.26		-0.06	-0.96	0.15	-0.27	0.27	-0.25	0.1	-0.13	-0.26	-0.25	-0.29	-0.06	-0.01
Net Income Per Share	0.19	0.0	-0.29	0.55	0.16	-0.34	-0.36	0.24	-0.29	0.16	-0.36	-0.02	-0.06		0.0	-0.32	0.05	-0.06	0.17	0.16	0.55	0.16	0.14	0.26	0.67	0.94
Days Of Inventory On Hand	0.18	-0.33	-0.25	-0.26	0.25	-0.19	-0.28	0.16	-0.25	0.2	-0.26	-0.28	-0.96	0.0		-0.01	0.26	-0.1	0.16	-0.19	0.1	0.21	0.16	0.15	0.07	-0.03
Payables Turnover	-0.54	-0.06	-0.24	-0.01	0.01	0.2	0.29	0.07	-0.24	-0.51	0.29	0.23	0.15	-0.32	-0.01		0.19	0.18	-0.28	-0.25	-0.43	0.15	-0.16	-0.94	-0.32	-0.24
Capex To Revenue	0.41	-0.53	0.51	0.06	-0.47	-0.62	-0.59	0.88	0.51	0.24	-0.62	0.01	-0.27	0.05	0.26	0.19		-0.53	0.56	0.09	0.37	0.85	0.61	-0.15	0.19	0.17
Cash Per Share	-0.27	0.08	-0.41	0.34	0.71	0.45	0.64	-0.6	-0.41	-0.06	0.64	-0.03	0.27	-0.06	-0.1	0.18	-0.53		-0.46	-0.18	-0.41	-0.6	-0.48	-0.31	-0.19	-0.24
Pocfratio	0.86	-0.62	0.49	0.09	-0.2	-0.82	-0.74	0.7	0.49	0.77	-0.75	-0.35	-0.25	0.17	0.16	-0.28	0.56	-0.46		-0.13	0.46	0.8	0.98	0.32	0.11	0.27
Interest Coverage	-0.22	0.33	0.04	-0.27	-0.43	0.02	-0.21	0.17	0.04	-0.38	-0.21	0.55	0.1	0.16	-0.19	-0.25	0.09	-0.18	-0.13		-0.03	0.0	-0.11	0.16	-0.03	0.19
Payout Ratio	0.55	-0.33	0.28	0.34	-0.1	-0.59	-0.62	0.42	0.28	0.46	-0.62	-0.46	-0.13	0.55	0.1	-0.43	0.37	-0.41	0.46	-0.03		0.39	0.41	0.43	0.91	0.61
Capex To Operating Cash Flow	0.51	-0.54	0.37	0.05	-0.38	-0.79	-0.76	0.95	0.37	0.36	-0.79	-0.13	-0.26	0.16	0.21	0.15	0.85	-0.6	0.8	0.0	0.39		0.86	-0.07	0.12	0.32
Pfcf Ratio	0.76	-0.57	0.47	0.09	-0.22	-0.77	-0.7	0.74	0.47	0.67	-0.71	-0.3	-0.25	0.14	0.16	-0.16	0.61	-0.48	0.98	-0.11	0.41	0.86		0.18	0.06	0.24
Days Payables Outstanding	0.57	-0.04	0.2	-0.18	-0.1	-0.31	-0.44	0.01	0.2	0.5	-0.42	-0.28	-0.29	0.26	0.15	-0.94	-0.15	-0.31	0.32	0.16	0.43	-0.07	0.18		0.28	0.26
Income Quality	0.26	-0.14	0.0	0.46	0.09	-0.32	-0.35	0.2	0.0	0.22	-0.36	-0.37	-0.06	0.67	0.07	-0.32	0.19	-0.19	0.11	-0.03	0.91	0.12	0.06	0.28		0.66
Roe	0.25	-0.1	-0.26	0.38	-0.01	-0.51	-0.57	0.43	-0.26	0.16	-0.56	-0.03	-0.01	0.94	-0.03	-0.24	0.17	-0.24	0.27	0.19	0.61	0.32	0.24	0.26	0.66

Click cells to compare fundamentals

Bristol Myers Account Relationship Matchups

Bristol Myers fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	3.29	2.99	3.32	2.36	2.37	2.95
Dividend Yield	0.0291	0.0317	0.0302	0.0447	0.0424	0.0274
Ptb Ratio	3.7	3.85	4.93	3.61	7.02	6.94
Days Sales Outstanding	72.98	98.49	110.21	123.79	81.21	60.07
Book Value Per Share	16.78	16.21	14.61	14.25	8.08	5.62
Free Cash Flow Yield	0.0588	0.0661	0.0949	0.11	0.078	0.13
Operating Cash Flow Per Share	6.22	7.3	6.13	6.7	7.49	7.87
Stock Based Compensation To Revenue	0.0183	0.0126	0.009901	0.0115	0.0105	0.00872
Capex To Depreciation	0.48	0.0725	0.0911	0.11	0.12	0.13
Pb Ratio	3.7	3.85	4.93	3.61	7.02	6.94
Ev To Sales	4.17	3.67	4.0	3.03	3.22	3.1
Free Cash Flow Per Share	5.89	6.86	5.61	6.11	6.88	7.22
Roic	0.0659	0.0951	0.11	0.22	0.25	0.21
Inventory Turnover	5.68	4.74	4.33	4.02	4.67	2.58
Net Income Per Share	(3.98)	3.15	2.97	3.88	(4.41)	(4.19)
Days Of Inventory On Hand	64.3	76.93	84.22	90.87	78.11	142.12
Payables Turnover	4.34	3.37	3.33	3.28	3.32	3.81
Capex To Revenue	0.0177	0.021	0.0242	0.0269	0.0258	0.0443
Cash Per Share	7.01	7.75	4.34	5.94	5.36	5.63
Pocfratio	9.97	8.54	11.73	7.66	7.55	7.17
Interest Coverage	3.61	7.62	8.38	14.79	17.01	20.56
Payout Ratio	(0.45)	0.63	0.73	0.59	(0.54)	(0.52)
Capex To Operating Cash Flow	0.0536	0.06	0.0856	0.0872	0.0822	0.0781
Pfcf Ratio	10.53	9.09	12.83	8.39	8.22	8.63
Days Payables Outstanding	84.11	108.29	109.46	111.24	110.03	91.31
Income Quality	(1.56)	2.31	2.06	1.72	(1.7)	(1.62)
Roe	(0.24)	0.19	0.2	0.27	(0.55)	(0.52)
Ev To Operating Cash Flow	12.61	10.5	14.15	9.82	10.24	9.73
Pe Ratio	(15.57)	19.8	24.22	13.23	(12.81)	(12.17)
Ev To Free Cash Flow	13.32	11.17	15.47	10.76	11.15	11.71
Intangibles To Total Assets	0.67	0.62	0.58	0.59	0.51	0.49
Net Debt To E B I T D A	7.37	1.57	1.64	1.55	12.9	13.54
Current Ratio	5.22	1.6	1.58	1.25	1.43	1.94
Tangible Book Value Per Share	(15.9)	(12.28)	(12.39)	(9.07)	(14.13)	(13.42)
Receivables Turnover	5.0	3.71	3.31	2.95	4.49	5.59
Shareholders Equity Per Share	16.75	16.18	14.58	14.22	8.06	5.74

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Bristol Historical Financial Ratios

About Bristol Financial Ratios Analysis

Bristol Myers Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Bristol Myers fundamentals Correlations

Bristol Myers Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bristol Myers fundamentals Accounts

Also Currently Popular

Additional Tools for Bristol Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 0.98	Pocfratio
Ev To Sales	+ 0.95	Price To Sales Ratio
Capex To Operating Cash Flow	+ 0.95	Capex To Depreciation
Roe	+ 0.94	Net Income Per Share

Days Of Inventory On Hand	- 0.96	Inventory Turnover
Days Payables Outstanding	- 0.94	Payables Turnover
Free Cash Flow Per Share	- 0.84	Capex To Depreciation
Capex To Depreciation	- 0.82	Operating Cash Flow Per Share
Pocfratio	- 0.82	Free Cash Flow Yield
Capex To Operating Cash Flow	- 0.79	Free Cash Flow Per Share